Transcranial Direct-Current Stimulation: Not Ready for Prime Time Yet
The Carlat Psychiatry Report, Volume 15, Number 12, December 2017
Michael Posternak, MD.
Dr. Posternak has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Transcranial magnetic stimulation (TMS) was approved by the FDA in 2009 for the treatment of major depression, but TMS is costly and has so far produced only mixed results.